Vitalhub (TSE:VHI) Given a C$7.50 Price Target by Cormark Analysts

Cormark set a C$7.50 price target on Vitalhub (TSE:VHI) in a report issued on Monday, BayStreet.CA reports. The firm currently has a buy rating on the stock.

VHI has been the topic of a number of other research reports. Eight Capital increased their price target on Vitalhub from C$5.00 to C$6.25 and gave the stock a buy rating in a research report on Tuesday, February 6th. Canaccord Genuity Group raised their target price on Vitalhub from C$5.25 to C$5.50 and gave the company a buy rating in a research report on Tuesday, February 6th.

Vitalhub Trading Up 3.1 %

Shares of VHI stock opened at C$6.00 on Monday. The company has a market capitalization of C$262.26 million, a P/E ratio of 60.00, a P/E/G ratio of 0.42 and a beta of 1.21. The business’s 50 day moving average is C$5.99 and its two-hundred day moving average is C$4.52. Vitalhub has a 12-month low of C$2.35 and a 12-month high of C$6.86.

Vitalhub (TSE:VHI) last issued its quarterly earnings results on Thursday, March 21st. The company reported C$0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of C$0.04 by C($0.01). The business had revenue of C$13.60 million for the quarter, compared to analysts’ expectations of C$13.68 million. Vitalhub had a return on equity of 5.78% and a net margin of 8.66%. On average, research analysts predict that Vitalhub will post 0.1501823 earnings per share for the current fiscal year.

Vitalhub Company Profile

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.